78
54
Growth Score 78 in past quarter
-6 pts
Heat Score 54 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
593957
Cure Hereditary Hemorrhagic Telangiectasia is a nonprofit organization that provides diagnosis and treatment options for telangiectasia.
- Chris Hughes: Chair, Scientific and Medical Advisory Council
About the Company
Cure Hereditary Hemorrhagic Telangiectasia offers a variety of educational materials and tools to help learn about that as well as connect with expert care. They find a hereditary hemorrhagic telangiectasia treatment center or explore their resource library. They are a nonprofit organization that provides diagnosis and treatment options for
telangiectasia.